Contineum Therapeutics, Inc. (CTNM) Capital expenditures 2023–2025
Contineum Therapeutics, Inc. (CTNM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$231,000FY2025 · since FY2023: $414,000 → $231,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $231,000 | -55.1% |
| FY2024 | $514,000 | +24.2% |
| FY2023 | $414,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice